| MANU P, DIMA L, SHULMAN M, et al. Weight Gain and Obesity in Schizophrenia:Epidemiology, Pathobiology, and Management[J]. Acta Psychiatrica Scandinavica, 2015, 132(2):97-108. doi: 10.1111/acps.12445 |
| TARDY M, HUHN M, KISSLING W, et al. Haloperidol Versus Low-Potency First-Generation Antipsychotic Drugs for Schizophrenia[J]. Cochrane Database Syst Rev, 2014(7):1-77. |
| 刘雪梅, 王伯初, 邓超, 等.二代抗精神病药物介导脂代谢紊乱的机制研究进展[J].中国药学杂志, 2016, 51(3):172-176. |
| KUROKI T, NAGAO N, NAKAHARA T. Neuropharmacology of Second-Generation Antipsychotic Drugs:a Validity of the Serotonin-Dopamine Hypothesis[J]. Progress in Brain Research, 2008, 172:199-212. doi: 10.1016/S0079-6123(08)00910-2 |
| CASEY A B, CANAL C E. Classics in Chemical Neuroscience:Aripiprazole[J]. ACS Chemical Neuroscience, 2017, 8(6):1135-1146. doi: 10.1021/acschemneuro.7b00087 |
| KIRINO E. Serum Prolactin Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Antipsychotics:Comparison Between Aripiprazole and other Atypical Antipsychotics[J]. Annals of General Psychiatry, 2017(16):43. |
| WESTON-GREEN K, HUANG X F, DENG C. Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain[J]. PLoS One, 2012, 7(3):e33548. doi: 10.1371/journal.pone.0033548 |
| DENG C, WESTON-GREEN K, HUANG X F. The Role of Histaminergic H1 and H3 Receptors in Food Intake:A Mechanism for Atypical Antipsychotic-induced Weight Gain[J]. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010, 34(1):1-4. doi: 10.1016/j.pnpbp.2009.11.009 |
| LAURESSERGUES E, MARTIN F, HELLEBOID A, et al. Overweight Induced by Chronic Risperidone Exposure is Correlated with Overexpression of the SREBP-1c and FAS Genes in Mouse Liver[J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 383(4):423-436. doi: 10.1007/s00210-010-0597-3 |
| LIU X M, DENG C, CAO S, et al. Acute Effects of Oral Olanzapine Treatment on the Expression of Fatty Acid and Cholesterol Metabolism-related Gene in Rats[J]. Life Sciences, 2015, 128:72-78. doi: 10.1016/j.lfs.2015.01.033 |
| 王园, 刘珂, 邱邴勋, 等.梓醇调控自噬和凋亡促进H2O2诱导的PC12细胞存活[J].西南大学学报(自然科学版), 2018, 40(2):27-34. |
| ZHANG Q S, HE M, DENG C, et al. Hypothalamic Ghrelin Signalling Mediates Olanzapine-induced Hyperphagia and Weight Gain in Female Rats[J]. The International Journal of Neuropsychopharmacology, 2014, 17(5):807-818. doi: 10.1017/S1461145713001697 |
| WESTON-GREEN K, HUANG X F, HAN M, et al. The Effects of Antipsychotics on the Density of Cannabinoid Receptors in the Dorsal Vagal Complex of Rats:Implications for Olanzapine-induced Weight Gain[J]. The International Journal of Neuropsychopharmacology, 2008, 11(6):827-835. |
| 吴小立, 魏钦令, 钟智勇, 等.精神分裂症患者糖代谢异常的探讨[J].中华精神科杂志, 2012, 45(6):327-330. doi: 10.3760/cma.j.issn.1006-7884.2012.06.002 |
| ANNAMALAI A, KOSIR U, TEK C. Prevalence of Obesity and Diabetes in Patients with Schizophrenia[J]. World Journal of Diabetes, 2017, 8(8):390. doi: 10.4239/wjd.v8.i8.390 |
| PARK S J, LEE Y, OH H K, et al. Oleanolic Acid Attenuates MK-801-induced Schizophrenia-like Behaviors in Mice[J]. Neuropharmacology, 2014, 86:49-56. doi: 10.1016/j.neuropharm.2014.06.025 |
| KIM T W, KANG H S, PARK J K, et al. Voluntary Wheel Running Ameliorates Symptoms of MK-801-induced Schizophrenia in Mice[J]. Molecular Medicine Reports, 2014, 10(6):2924-2930. doi: 10.3892/mmr.2014.2644 |
| XIU Y, KONG X R, ZHANG L, et al. White Matter Injuries Induced by MK-801 in a Mouse Model of Schizophrenia Based on NMDA Antagonism[J]. Anatomical Record, 2014, 297(8):1498-1507. doi: 10.1002/ar.22942 |
| VAN WEENEN J E D L, PARLEVLIET E T, SCHRÖDER-VAN DER ELST JPS V, et al. Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice[J]. Experimental Diabetes Research, 2011(10):1-10. |
| BROWN M S, GOLDSTEIN J L. The SREBP Pathway:Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor[J]. Cell, 1997, 89(3):331-340. doi: 10.1016/S0092-8674(00)80213-5 |
| FERNO J. Lipogenic Effects of Psychotropic Drugs:Focus on the SREBP System[J]. Frontiers in Bioscience, 2011, 16(1):49-60. doi: 10.2741/3675 |
| LAUNDON W, MUZYK A J, GAGLIARDI J P, et al. Prevalence of Baseline Lipid Monitoring in Patients Prescribed Second-generation Antipsychotics during Their Index Hospitalization:A Retrospective Cohort Study[J]. General Hospital Psychiatry, 2012, 34(4):380-384. doi: 10.1016/j.genhosppsych.2012.03.016 |
| JIA H Y, LI Q Z, LV L F. HDAC5 Inhibits Hepatic Lipogenic Genes Expression by Attenuating the Transcriptional Activity of Liver X Receptor[J]. Cellular Physiology and Biochemistry, 2016, 39(4):1561-1567. doi: 10.1159/000447858 |
| LIU X M, LIAN J M, HU C H, et al. Betahistine Co-treatment Ameliorates Dyslipidemia Induced by Chronic Olanzapine Treatment in Rats through Modulation of Hepatic AMPKα-SREBP-1 and PPARα-dependent Pathways[J]. Pharmacological Research, 2015, 100:36-46. doi: 10.1016/j.phrs.2015.07.023 |
| CAI H L, TAN Q Y, JIANG P, et al. A Potential Mechanism Underlying Atypical Antipsychotics-induced Lipid Disturbances[J]. Translational Psychiatry, 2015, 5(10):e661. doi: 10.1038/tp.2015.161 |
| HUANG X F, HAN M, HUANG X, et al. Olanzapine Differentially Affects 5-HT2A and 2C Receptor mRNA Expression in the Rat Brain[J]. Behavioural Brain Research, 2006, 171(2):355-362. doi: 10.1016/j.bbr.2006.03.040 |
| HE M, ZHANG Q S, DENG C, et al. Time-dependent Effects of Olanzapine Treatment on the Expression of Histidine Decarboxylase, H1 and H3 Receptor in the Rat Brain:The Roles in Olanzapine-induced Obesity[J]. Psychoneuroendocrinology, 2017, 85:190-199. doi: 10.1016/j.psyneuen.2017.08.022 |
| LIAN J M, HUANG X F, PAI N, et al. Betahistine Ameliorates Olanzapine-induced Weight Gain through Modulation of Histaminergic, NPY and AMPK Pathways[J]. Psychoneuroendocrinology, 2014, 48:77-86. doi: 10.1016/j.psyneuen.2014.06.010 |
| HE M, ZHANG Q S, DENG C, et al. Olanzapine-Activated AMPK Signaling in the Dorsal Vagal Complex is Attenuated by Histamine H1 Receptor Agonist in Female Rats[J]. Endocrinology, 2014, 155(12):4895-4904. doi: 10.1210/en.2014-1326 |
| KIM S F, HUANG A S, SNOWMAN A M, et al. Antipsychotic Drug-induced Weight Gain Mediated by Histamine H1 Receptor-linked Activation of Hypothalamic AMP-kinase[J]. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(9):3456-3459. doi: 10.1073/pnas.0611417104 |
| LIAN J M, HUANG X F, PAI N, et al. Ameliorating Antipsychotic-induced Weight Gain by Betahistine:Mechanisms and Clinical Implications[J]. Pharmacological Research, 2016, 106:51-63. doi: 10.1016/j.phrs.2016.02.011 |